Jerusalem Pharmaceuticals Revenue

In the year 2025, Jerusalem Pharmaceuticals had annual revenue of $49.93M USD with 25.39% growth. Jerusalem Pharmaceuticals had revenue of $16.10M in the quarter ending December 31, 2025, with 20.87% growth.

Revenue

$49.93M

Revenue Growth

+25.39%

P/S Ratio

1.68

Revenue / Employee

$94.03K

Employees

531

Market Cap

59.33M JOD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.93M	10.11M	25.39%
Dec 31, 2024	39.82M	168.20K	0.42%
Dec 31, 2023	39.65M	-6.49M	-14.06%
Dec 31, 2022	46.14M	-82.72K	-0.18%
Dec 31, 2021	46.23M	9.83M	27.00%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Trust International Insurance Co. P.L.C	90.63M
Palestine Industrial Investment Company	60.00M
Arab Islamic Bank P.L.C.	45.52M
National Insurance Company (Palestine)	40.82M
Palestine Poultry Company L.T.D	38.58M
Quds Bank	38.40M
The National Bank	34.12M
Palestine Islamic Bank	33.21M

Revenue Rankings